Anavex Life Sciences Corp (AVXL) - Financial and Strategic SWOT Analysis Review

February 2021 | 46 pages | ID: A19E1F5C3E5EN
GlobalData

Abstracts

Anavex Life Sciences Corp (AVXL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – Analyst’s summarization of the company’s business strategy.
• SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
• Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
• Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Anavex Life Sciences Corp (Anavex) is a clinical-stage biopharmaceutical company that focuses on developing differentiated therapeutics for the treatment of neurodegenerative and other central nervous systems (CNS) diseases, pain and various types of cancer. The company’s target indications include Alzheimer’s disease, Parkinson’s disease, Rett syndrome, epilepsy, neuropathic pain, depression, prostate cancer, pancreatic cancer infantile spasms, fragile X syndrome, Angelman syndrome, multiple sclerosis, depression, stroke, frontotemporal dementia, visceral pain, acute and neuropathic Pain and malignant melanoma. Its pipeline comprises one drug candidate and several compounds in diverse stages of pre-clinical study. Anavex's lead compound ANAVEX 2-73 is being developed for the treatment of Alzheimer’s disease, Parkinson’s disease and potentially other CNS diseases, including rare diseases. Anavex is headquartered in New York, the US.

Anavex Life Sciences Corp Key Recent Developments

Feb 22,2021: Anavex Life Sciences announces participation at upcoming Worldwide National Institutes of Health (NIH) panel at Rare Disease Day
Feb 19,2021: Anavex Life Sciences announces participation at Precision in Clinical Trials Virtual Summit
Feb 11,2021: Anavex Life Sciences Reports Fiscal 2021 First Quarter Financial Results And Business Outlook
Feb 08,2021: Anavex Life Sciences to Announce Fiscal 2021 First Quarter Financial Results and Business Outlook on Thursday, February 11, 2021
Dec 28,2020: Anavex Life Sciences reports fiscal 2020 year end financial results and clinical program updates

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

• The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

• The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

• Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

• Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

• Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Contents

Table of Contents
List of Tables
List of Figures

SECTION 1 - ABOUT THE COMPANY

Anavex Life Sciences Corp - Key Facts
Anavex Life Sciences Corp - Key Employees
Anavex Life Sciences Corp - Key Employee Biographies
Anavex Life Sciences Corp - Major Products and Services
Anavex Life Sciences Corp - History
Anavex Life Sciences Corp - Company Statement
Anavex Life Sciences Corp - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Company Overview
Anavex Life Sciences Corp - Business Description
R&D Overview
Anavex Life Sciences Corp - Corporate Strategy
Anavex Life Sciences Corp - SWOT Analysis
SWOT Analysis - Overview
Anavex Life Sciences Corp - Strengths
Anavex Life Sciences Corp - Weaknesses
Anavex Life Sciences Corp - Opportunities
Anavex Life Sciences Corp - Threats
Anavex Life Sciences Corp - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Anavex Life Sciences Corp, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Anavex Life Sciences Corp, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Anavex Life Sciences Corp, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Feb 22, 2021: Anavex Life Sciences announces participation at upcoming Worldwide National Institutes of Health (NIH) panel at Rare Disease Day
Feb 19, 2021: Anavex Life Sciences announces participation at Precision in Clinical Trials Virtual Summit
Feb 11, 2021: Anavex Life Sciences Reports Fiscal 2021 First Quarter Financial Results And Business Outlook
Feb 08, 2021: Anavex Life Sciences to Announce Fiscal 2021 First Quarter Financial Results and Business Outlook on Thursday, February 11, 2021
Dec 28, 2020: Anavex Life Sciences reports fiscal 2020 year end financial results and clinical program updates
Aug 06, 2020: Anavex Life Sciences reports fiscal 2020 third quarter financial results and provides business updates
May 07, 2020: Anavex Life Sciences reports fiscal 2020 second quarter financial results and provides business updates
Mar 31, 2020: Anavex Life Sciences provides update on clinical program development as response to covid-19
Feb 06, 2020: Anavex Life Sciences reports fiscal 2020 first quarter financial results and provides clinical study updates
Feb 04, 2020: Anavex Life Sciences to present and participate in a panel at the 2020 BIO CEO & Investor Conference

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

Anavex Life Sciences Corp, Key Facts
Anavex Life Sciences Corp, Key Employees
Anavex Life Sciences Corp, Key Employee Biographies
Anavex Life Sciences Corp, Major Products and Services
Anavex Life Sciences Corp, History
Anavex Life Sciences Corp, Subsidiaries
Anavex Life Sciences Corp, Key Competitors
Anavex Life Sciences Corp, Ratios based on current share price
Anavex Life Sciences Corp, Annual Ratios
Anavex Life Sciences Corp, Interim Ratios
Anavex Life Sciences Corp, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Anavex Life Sciences Corp, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Anavex Life Sciences Corp, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures

LIST OF FIGURES

Anavex Life Sciences Corp, Performance Chart (2016 - 2020)
Anavex Life Sciences Corp, Ratio Charts
Anavex Life Sciences Corp, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Anavex Life Sciences Corp, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021

COMPANIES MENTIONED

Pfizer Inc
Novartis AG
Merck & Co Inc
Johnson & Johnson
GlaxoSmithKline Plc
F. Hoffmann-La Roche Ltd
Eli Lilly and Co
Biogen Inc
AbbVie Inc